PMID- 9720889 OWN - NLM STAT- MEDLINE DCOM- 19981130 LR - 20190815 IS - 0142-9612 (Print) IS - 0142-9612 (Linking) VI - 19 IP - 14 DP - 1998 Jul TI - Effects of biodegradable polymer particles on rat marrow-derived stromal osteoblasts in vitro. PG - 1255-68 AB - Effects of biodegradable particles of poly(L-lactic acid) (PLLA) and poly(DL-lactic-co-glycolic acid) (PLGA) 50/50 with diameter ranging from 1.0 to 1.5 microm on rat marrow stromal osteoblasts in vitro have been investigated over a period of 28 days. This study examined the effects of three particle parameters, concentration, polymer molecular weight, and composition, on osteoblast proliferation and function. Cell cultures were challenged with particles at two different time points: upon cell seeding (Day 1), and after cells had begun to establish their own mineralized extracellular matrix (Day 14). The most significant trend observed in those cultures challenged with particles beginning on Day 1 was due to increasing the concentration of particles, resulting in decreased [3H]-thymidine incorporation, cell count, and mineralization. Those cultures challenged with particles beginning on Day 14 were significantly more mineralized than those challenged with particles beginning on Day 1. In addition, increasing osteocalcin secretion confirmed the osteoblastic phenotype of the derived stromal cells. These studies suggest that the particles may affect the bone remodeling process surrounding a degrading implant by direct interaction with osteoblasts in addition to their indirect contributions to the inflammatory mechanism via mediators secreted by macrophages upon their phagocytosis. FAU - Wake, M C AU - Wake MC AD - Institute of Biosciences and Bioengineering and Department of Chemical Engineering, Rice University, Houston, TX 77251-1892, USA. FAU - Gerecht, P D AU - Gerecht PD FAU - Lu, L AU - Lu L FAU - Mikos, A G AU - Mikos AG LA - eng GR - R29-AR42639/AR/NIAMS NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - Netherlands TA - Biomaterials JT - Biomaterials JID - 8100316 RN - 0 (Biocompatible Materials) RN - 0 (Polyesters) RN - 0 (Polymers) RN - 104982-03-8 (Osteocalcin) RN - 1SIA8062RS (Polylactic Acid-Polyglycolic Acid Copolymer) RN - 26009-03-0 (Polyglycolic Acid) RN - 33X04XA5AT (Lactic Acid) RN - 459TN2L5F5 (poly(lactide)) RN - EC 3.1.3.1 (Alkaline Phosphatase) SB - IM MH - Alkaline Phosphatase/metabolism MH - Animals MH - Biocompatible Materials/*pharmacology MH - Biodegradation, Environmental MH - Bone Marrow Cells/drug effects MH - Bone Remodeling MH - Cell Division/drug effects MH - Cells, Cultured MH - Dose-Response Relationship, Drug MH - Lactic Acid/*pharmacology MH - Male MH - Molecular Weight MH - Osteoblasts/*drug effects MH - Osteocalcin/metabolism MH - Particle Size MH - Polyesters MH - Polyglycolic Acid/*pharmacology MH - Polylactic Acid-Polyglycolic Acid Copolymer MH - Polymers/*pharmacology MH - Prostheses and Implants MH - Rats MH - Rats, Sprague-Dawley OTO - NASA OT - Non-programmatic EDAT- 1998/08/28 00:00 MHDA- 1998/08/28 00:01 CRDT- 1998/08/28 00:00 PHST- 1998/08/28 00:00 [pubmed] PHST- 1998/08/28 00:01 [medline] PHST- 1998/08/28 00:00 [entrez] AID - S0142961298000222 [pii] AID - 10.1016/s0142-9612(98)00022-2 [doi] PST - ppublish SO - Biomaterials. 1998 Jul;19(14):1255-68. doi: 10.1016/s0142-9612(98)00022-2.